130 related articles for article (PubMed ID: 30674477)
1. Individual-level and country-level socioeconomic determinants of disease outcomes in SpA: multinational, cross-sectional study (ASAS-COMOSPA).
Putrik P; Ramiro S; Moltó A; Keszei AP; Norton S; Dougados M; van der Heijde D; Landewé RBM; Boonen A
Ann Rheum Dis; 2019 Apr; 78(4):486-493. PubMed ID: 30674477
[TBL] [Abstract][Full Text] [Related]
2. Inequity in biological DMARD prescription for spondyloarthritis across the globe: results from the ASAS-COMOSPA study.
Nikiphorou E; van der Heijde D; Norton S; Landewé RB; Molto A; Dougados M; Van den Bosch FE; Ramiro S
Ann Rheum Dis; 2018 Mar; 77(3):405-411. PubMed ID: 29222349
[TBL] [Abstract][Full Text] [Related]
3. Individual-level and country-level socio-economic factors and health outcomes in spondyloarthritis: analysis of the ASAS-perSpA study.
Capelusnik D; Zhao SS; Boonen A; Ziade N; Medina CL; Dougados M; Nikiphorou E; Ramiro S
Rheumatology (Oxford); 2022 May; 61(5):2043-2053. PubMed ID: 34387300
[TBL] [Abstract][Full Text] [Related]
4. Lower education and living in countries with lower wealth are associated with higher disease activity in rheumatoid arthritis: results from the multinational COMORA study.
Putrik P; Ramiro S; Keszei AP; Hmamouchi I; Dougados M; Uhlig T; Kvien TK; Boonen A
Ann Rheum Dis; 2016 Mar; 75(3):540-6. PubMed ID: 25630346
[TBL] [Abstract][Full Text] [Related]
5. Work participation in spondyloarthritis across countries: analysis from the ASAS-COMOSPA study.
Rodrigues Manica S; Sepriano A; Ramiro S; Pimentel Santos F; Putrik P; Nikiphorou E; Norton S; Molto A; Dougados M; van der Heijde D; Landewé RBM; van den Bosch FE; Boonen A
Ann Rheum Dis; 2018 Sep; 77(9):1303-1310. PubMed ID: 29860232
[TBL] [Abstract][Full Text] [Related]
6. Sex differential impact of comorbidities in spondyloarthritis: data from COMOSPA study.
Llop M; Gratacós J; Moreno M; Arevalo Salaet M; Calvet J; Berenguer-Llergo A; Dougados M; Molto A; López-Medina C
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38296312
[TBL] [Abstract][Full Text] [Related]
7. Validation of disease activity and functional status questionnaires in spondyloarthritis.
Quinzanos I; Luong PT; Bobba S; Steuart Richards J; Majithia V; Davis LA; Caplan L
Clin Exp Rheumatol; 2015; 33(2):146-52. PubMed ID: 25664820
[TBL] [Abstract][Full Text] [Related]
8. Gender difference in ASAS HI among patients with ankylosing spondylitis.
Chen HH; Chen YM; Lai KL; Hsieh TY; Hung WT; Lin CT; Tseng CW; Tang KT; Chou YY; Wu YD; Huang CY; Hsieh CW; Huang WN; Chen YH
PLoS One; 2020; 15(7):e0235678. PubMed ID: 32645080
[TBL] [Abstract][Full Text] [Related]
9. Association of Comorbidities in Spondyloarthritis With Poor Function, Work Disability, and Quality of Life: Results From the Assessment of SpondyloArthritis International Society Comorbidities in Spondyloarthritis Study.
Nikiphorou E; Ramiro S; van der Heijde D; Norton S; Moltó A; Dougados M; van den Bosch F; Landewé R;
Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1257-1262. PubMed ID: 29125900
[TBL] [Abstract][Full Text] [Related]
10. Validation and reliability of translation of the ASAS Health Index in a Colombian Spanish-speaking population with spondyloarthritis.
Bautista-Molano W; Landewé RBM; Kiltz U; Valle-Oñate R; van der Heijde D
Clin Rheumatol; 2018 Nov; 37(11):3063-3068. PubMed ID: 30259248
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
Ciurea A; Scherer A; Exer P; Bernhard J; Dudler J; Beyeler B; Kissling R; Stekhoven D; Rufibach K; Tamborrini G; Weiss B; Müller R; Nissen MJ; Michel BA; van der Heijde D; Dougados M; Boonen A; Weber U;
Arthritis Rheum; 2013 Dec; 65(12):3096-106. PubMed ID: 23983141
[TBL] [Abstract][Full Text] [Related]
12. The Prevalence of Renal Impairment in Patients with Spondyloarthritis: Results from the International ASAS-COMOSPA Study.
Couderc M; Pereira B; Molto A; Tiple A; Soubrier M; Dougados M
J Rheumatol; 2018 Jun; 45(6):795-801. PubMed ID: 29657148
[TBL] [Abstract][Full Text] [Related]
13. Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis.
Kiltz U; van der Heijde D; Boonen A; Akkoc N; Bautista-Molano W; Burgos-Vargas R; Wei JC; Chiowchanwisawakit P; Dougados M; Duruoz MT; Elzorkany BK; Gaydukova I; Gensler LS; Gilio M; Grazio S; Gu J; Inman RD; Kim TJ; Navarro-Compan V; Marzo-Ortega H; Ozgocmen S; Pimentel Dos Santos F; Schirmer M; Stebbings S; Van den Bosch FE; van Tubergen A; Braun J
Ann Rheum Dis; 2018 Sep; 77(9):1311-1317. PubMed ID: 29858176
[TBL] [Abstract][Full Text] [Related]
14. Brief Report: Clinical Course Over Two Years in Patients With Early Nonradiographic Axial Spondyloarthritis and Patients With Ankylosing Spondylitis Not Treated With Tumor Necrosis Factor Blockers: Results From the German Spondyloarthritis Inception Cohort.
Poddubnyy D; Haibel H; Braun J; Rudwaleit M; Sieper J
Arthritis Rheumatol; 2015 Sep; 67(9):2369-75. PubMed ID: 26017497
[TBL] [Abstract][Full Text] [Related]
15. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.
Pedersen SJ; Sørensen IJ; Hermann KG; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Johansen JS; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Hansen A; Ostergaard M
Ann Rheum Dis; 2010 Jun; 69(6):1065-71. PubMed ID: 19740906
[TBL] [Abstract][Full Text] [Related]
16. Fibromyalgia in Spondyloarthritis: Effect on Disease Activity Assessment in Clinical Practice.
Wach J; Letroublon MC; Coury F; Tebib JG
J Rheumatol; 2016 Nov; 43(11):2056-2063. PubMed ID: 27633820
[TBL] [Abstract][Full Text] [Related]
17. Association between individual and country-level socioeconomic factors and work participation in spondyloarthritis including psoriatic arthritis: Analysis of the ASAS-perSpA study.
Zhao SS; Nikiphorou E; Boonen A; López-Medina C; Dougados M; Ramiro S
Semin Arthritis Rheum; 2021 Aug; 51(4):804-812. PubMed ID: 34153894
[TBL] [Abstract][Full Text] [Related]
18. The performance of different classification criteria sets for spondyloarthritis in the worldwide ASAS-COMOSPA study.
Bakker P; Moltó A; Etcheto A; Van den Bosch F; Landewé R; van Gaalen F; Dougados M; van der Heijde D
Arthritis Res Ther; 2017 May; 19(1):96. PubMed ID: 28511725
[TBL] [Abstract][Full Text] [Related]
19. Anti-drug antibodies and low serum trough infliximab levels correlate with disease activity measures in spondyloarthritis patients on an as-needed infliximab treatment.
Patil A; Upadhyaya S; Dawar R; Dadhaniya N; Sood I; Gupta SJ; Handa R
Int J Rheum Dis; 2019 Sep; 22(9):1638-1643. PubMed ID: 31211501
[TBL] [Abstract][Full Text] [Related]
20. Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: results from a phase III randomized trial.
Sieper J; Landewé R; Rudwaleit M; van der Heijde D; Dougados M; Mease PJ; Braun J; Deodhar A; Kivitz A; Walsh J; Hoepken B; Nurminen T; Maksymowych WP
Arthritis Rheumatol; 2015 Mar; 67(3):668-77. PubMed ID: 25470228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
